Table 8

Multinomial or binary logistic regression models
Compared groups HRV measure, factor or covariate β p OR 95% CI of OR
Normal eGFR versus Moderate decreased eGFR Intercept 5.971 0.021
LF/HF 1.000 0.038 2.718 1.057 to 6.984
Systolic BP −0.003 0.779 0.997 0.974 to 1.020
Age −0.109 <0.001 0.897 0.847 to 0.948
Absence of family history of hypertension 1.082 0.047 2.951 1.014 to 8.588
Mild decreased eGFR versus Moderate decreased eGFR Intercept 0.527 0.819
LF/HF 0.969 0.034 2.637 1.075 to 6.465
Systolic BP 0.024 0.027 1.024 1.003 to 1.046
Age −0.058 0.020 0.943 0.898 to 0.991
Absence of family history of hypertension 0.710 0.122 2.034 0.827 to 5.001
Normal IMT group versus Plaque group1 Intercept 5.552 0.002
SDNN 0.018 0.024 1.018 1.002 to 1.033
Age −0.169 <0.001 0.844 0.796 to 0.896
Absence of family history of hypertension 0.347 0.532 1.415 0.476 to 4.211
Thickening group versus Plaque group1 Intercept 2.688 0.101
SDNN 0.005 0.446 1.005 0.992 to 1.019
Age −0.080 0.001 0.923 0.879 to 0.970
Absence of family history of hypertension −1.072 0.071 0.342 0.107 to 1.096
Normal IMT group versus Plaque group1 Intercept 5.777 0.001
SDANN 0.017 0.021 1.017 1.003 to 1.032
Age −0.169 <0.001 0.845 0.797 to 0.696
Absence of family history of hypertension 0.357 0.523 1.429 0.478 to 4.270
Thickening group versus Plaque group1 Intercept 2.626 0.101
SDANN 0.006 0.351 1.006 0.993 to 1.020
Age −0.080 0.001 0.923 0.879 to 0.970
Absence of family history of hypertension −1.059 0.075 0.347 0.108 to 1.112
group with Hypertrophy versus group without Hypertrophy2 Intercept −5.240 0.004 0.005
LF/HF −0.155 0.528 0.856 0.563 to 1.302
Age 0.068 <0.001 1.071 1.036 to 1.107
Cholesterol −0.006 0.141 0.994 0.986 to 1.002
Diuretics −0.854 0.011 0.426 0.220 To 0.823

β: regression coefficient.

p: p-value referred to each variable in the regressions (multinomial or binary logistic).

OR: odds ratio, which is exp(β).

95% CI: 95% confidence interval.

1 multinomial logistic regression.

2 binary logistic regression.

Melillo et al.

Melillo et al. BMC Cardiovascular Disorders 2012 12:105   doi:10.1186/1471-2261-12-105

Open Data